SHC Relative Valuation
SHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SHC is overvalued; if below, it's undervalued.
Historical Valuation
Sotera Health Co (SHC) is now in the Fair zone, suggesting that its current forward PE ratio of 17.96 is considered Fairly compared with the five-year average of 19.94. The fair price of Sotera Health Co (SHC) is between 15.84 to 24.32 according to relative valuation methord.
Relative Value
Fair Zone
15.84-24.32
Current Price：16.56
Fair
17.96
PE
1Y
3Y
5Y
Trailing
Forward
11.04
EV/EBITDA
Sotera Health Co. (SHC) has a current EV/EBITDA of 11.04. The 5-year average EV/EBITDA is 12.64. The thresholds are as follows: Strongly Undervalued below 5.15, Undervalued between 5.15 and 8.90, Fairly Valued between 16.39 and 8.90, Overvalued between 16.39 and 20.13, and Strongly Overvalued above 20.13. The current Forward EV/EBITDA of 11.04 falls within the Historic Trend Line -Fairly Valued range.
12.91
EV/EBIT
Sotera Health Co. (SHC) has a current EV/EBIT of 12.91. The 5-year average EV/EBIT is 14.71. The thresholds are as follows: Strongly Undervalued below 6.25, Undervalued between 6.25 and 10.48, Fairly Valued between 18.95 and 10.48, Overvalued between 18.95 and 23.18, and Strongly Overvalued above 23.18. The current Forward EV/EBIT of 12.91 falls within the Historic Trend Line -Fairly Valued range.
3.99
PS
Sotera Health Co. (SHC) has a current PS of 3.99. The 5-year average PS is 4.64. The thresholds are as follows: Strongly Undervalued below 1.08, Undervalued between 1.08 and 2.86, Fairly Valued between 6.42 and 2.86, Overvalued between 6.42 and 8.21, and Strongly Overvalued above 8.21. The current Forward PS of 3.99 falls within the Historic Trend Line -Fairly Valued range.
14.44
P/OCF
Sotera Health Co. (SHC) has a current P/OCF of 14.44. The 5-year average P/OCF is 15.57. The thresholds are as follows: Strongly Undervalued below -6.26, Undervalued between -6.26 and 4.65, Fairly Valued between 26.49 and 4.65, Overvalued between 26.49 and 37.41, and Strongly Overvalued above 37.41. The current Forward P/OCF of 14.44 falls within the Historic Trend Line -Fairly Valued range.
19.59
P/FCF
Sotera Health Co. (SHC) has a current P/FCF of 19.59. The 5-year average P/FCF is 22.45. The thresholds are as follows: Strongly Undervalued below -1.43, Undervalued between -1.43 and 10.51, Fairly Valued between 34.39 and 10.51, Overvalued between 34.39 and 46.33, and Strongly Overvalued above 46.33. The current Forward P/FCF of 19.59 falls within the Historic Trend Line -Fairly Valued range.
Sotera Health Co (SHC) has a current Price-to-Book (P/B) ratio of 8.55. Compared to its 3-year average P/B ratio of 9.59 , the current P/B ratio is approximately -10.85% higher. Relative to its 5-year average P/B ratio of 9.96, the current P/B ratio is about -14.19% higher. Sotera Health Co (SHC) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -1.76%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -0.11% , the current FCF yield is about -100.00% lower.
8.55
P/B
Median3y
9.59
Median5y
9.96
1.81
FCF Yield
Median3y
-1.76
Median5y
-0.11
Competitors Valuation Multiple
The average P/S ratio for SHC's competitors is , providing a benchmark for relative valuation. Sotera Health Co Corp (SHC) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 9.05%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SHC increased by 21.05% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 5.95 to 15.55.
The secondary factor is the Revenue Growth, contributed 9.05%to the performance.
Overall, the performance of SHC in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Sotera Health Co (SHC) currently overvalued or undervalued?
What is Sotera Health Co (SHC) fair value?
How does SHC's valuation metrics compare to the industry average?
What is the current P/B ratio for Sotera Health Co (SHC) as of Dec 05 2025?
What is the current FCF Yield for Sotera Health Co (SHC) as of Dec 05 2025?
What is the current Forward P/E ratio for Sotera Health Co (SHC) as of Dec 05 2025?